A column published in The New York Times claimed the public was "badly misled" about the origins of COVID, even after its own ...

Five years after the World Health Organization declared a global pandemic, there has been progress — and backsliding in the ...

The following is a summary of “A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 ...

Frequent mutations of SARS-CoV-2 have reduced the effectiveness of vaccines, highlighting the need for mutation-resistant ...

Five young volunteers here have been deliberately exposed to the Covid-19 virus in the country’s first human challenge study, ...

Hello Anna, please note the words highlighted in bold type. I added them based on the sources you mentioned. Are they okay?

Scientists have learned more about how SARS-CoV-2 infections, which cause COVID-19, can ruin the ability of immune cells to ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations ...

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...

In a statement, the hospital stated that this is an isolated case and has advised all to stay cautious and prevent its spread ...

That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...

Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...